CIBMTR

AcronymDefinition
CIBMTRCenter for International Blood and Marrow Transplant Research
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
This was similar to the results from CIBMTR that the use of TBI as a part of conditioning significantly improved PFS.[25] TBI containing regimen was eligible for high-risk PTCLs because of efficacy and acceptable toxicity.
This will need to be examined in larger retrospective multicenter studies like CIBMTR and prospective clinical trials.
According to CIBMTR risk stratification7 using 10 variables our patient had three variables (female to male transplant, prior acute GVHD, time to cGVHD <5 months).
We analyzed the rate and pattern of abandonment of HDC/HCT for breast cancer using data from the CIBMTR. The CIBMTR is a voluntary consortium involving more than 500 transplant centers in 54 countries.
Influence of age and histology on outcome in adult non-hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center for International Blood & Marrow Transplant Research (CIBMTR).
Actinium Pharmaceuticals announced that new data from the ongoing pivotal Phase 3 SIERRA trial for Iomab-B was reported in a late breaking oral presentation at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR that was held on February 20th - 24th.
Backed by the industry-leading experience of the National Marrow Donor Program/Be The Match, and a research partnership with the CIBMTR (Center for International Blood and Marrow Transplant Research), the organization designs solutions that advance cell and gene therapies in any stage of development.
The largest retrospective trial was reported by Center for International Blood and Marrow Transplant Research (CIBMTR) in which higher relapse and inferior survival rates were detected after RIC transplants (47).
WALTHAM, Mass., April 30, 2013 -- ViaCord, PerkinElmer's family cord blood and tissue preservation business, is collaborating with the Center for International Blood and Marrow Transplant Research (CIBMTR) to collect, maintain and publish research from ViaCord's cord blood stem cell transplants.
WALTHAM, Mass., April 30, 2013--ViaCord, PerkinElmer's family cord blood and tissue preservation business, is collaborating with the Center for International Blood and Marrow Transplant Research (CIBMTR) to collect, maintain and publish research from ViaCord's cord blood stem cell transplants.
Equally relevant will be the ability of the application to work across clinical disciplines and with outside parties, including relevant information transfer between cell therapy and interfacing with the UNOS and CIBMTR registries.